BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 21799206)

  • 1. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
    Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
    Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease.
    Niihata K; Tomosugi N; Uehata T; Shoji T; Mitsumoto K; Shimizu M; Kawabata H; Sakaguchi Y; Suzuki A; Hayashi T; Okada N; Isaka Y; Rakugi H; Tsubakihara Y
    Nephrol Dial Transplant; 2012 Dec; 27(12):4378-85; discussion 4384-5. PubMed ID: 22833619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
    Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
    Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do serum hepcidin-25 levels correlate with oxidative stress in patients with chronic kidney disease not receiving dialysis?
    Maruyama Y; Yokoyama K; Yamamoto H; Nakayama M; Hosoya T
    Clin Nephrol; 2012 Oct; 78(4):281-6. PubMed ID: 22541685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate.
    Peters HP; Laarakkers CM; Swinkels DW; Wetzels JF
    Nephrol Dial Transplant; 2010 Mar; 25(3):848-53. PubMed ID: 19854845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
    Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
    Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
    Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A
    Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
    Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
    Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
    Niikura T; Maruyama Y; Nakashima S; Matsuo N; Tanno Y; Ohkido I; Yokoyama K; Yamamoto H; Yokoo T
    Ther Apher Dial; 2019 Aug; 23(4):341-346. PubMed ID: 30411489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome.
    Kato A
    Future Cardiol; 2010 Nov; 6(6):769-71. PubMed ID: 21142632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
    Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
    Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis.
    Kuragano T; Itoh K; Shimonaka Y; Kida A; Furuta M; Kitamura R; Yahiro M; Nanami M; Otaki Y; Hasuike Y; Nonoguchi H; Nakanishi T
    Nephrol Dial Transplant; 2011 Aug; 26(8):2663-7. PubMed ID: 21245128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?
    Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Mysliwiec M
    Am J Nephrol; 2005; 25(6):586-90. PubMed ID: 16254410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible role of hepcidin in the pathogenesis of anemia in heart allograft recipients.
    Przybylowski P; Malyszko J; Malyszko JS
    Transplant Proc; 2010 Jun; 42(5):1803-7. PubMed ID: 20620527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
    Malyszko J; Malyszko JS; Mysliwiec M
    Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation.
    Kuragano T; Shimonaka Y; Kida A; Furuta M; Nanami M; Otaki Y; Hasuike Y; Nonoguchi H; Nakanishi T
    Am J Nephrol; 2010; 31(6):534-40. PubMed ID: 20484891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
    Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.